41422-67-7

Basic information

• Product Name: Benzenetellurol, sodium salt
• CAS NO: 41422-67-7
• Molecular Formula: C6H6Te.Na
• Molecular Weight: 227.695
• Mol File: 41422-67-7.mol
• Article Data: 15

Chemical Properties

• CAS DataBase Reference: Benzenetellurol, sodium salt(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenetellurol, sodium salt(41422-67-7)
• EPA Substance Registry System: Benzenetellurol, sodium salt(41422-67-7)

Safety Data

• Hazardous Substances Data: 41422-67-7(Hazardous Substances Data)

Upstream product

• 73296-31-8 phenyltellurotrimethylsilane 
• 52251-60-2 benzenetellurolate lithium salt 
• 591-51-5 phenyllithium 
• 32294-60-3 diphenyl ditelluride 

Downstream Products

• 107840-06-2 C₁₄H₁₂S₂Te 
• 145509-76-8 axial 1-(phenyltelluro)cis-3,5-diphenylcyclohexane 
• 109179-40-0 1,2-Bis-phenyltellanylmethyl-benzene 
• 158750-93-7 1,1,1,2,2,3,3,4,4-nonafluoro-6-iodo-5-decene 
• 180588-31-2 2-methyl-1-propyl (phenyltelluro)formate 
• 180588-36-7 cyclohexyl (phenyltelluro)formate 
• 872-89-9 methylphenyltelluride 
• 1229183-76-9 isopropyl-(7-isopropylimino-4-phenyltellanylcyclohepta-1,3,5-trienyl)amine 

Relevant articles and documents

Photolysis of phenyltellurotrifluoroacetimidates; a new approach to generation of α-trifluoroacetimidoyl radicals leading to the synthesis of indole derivatives

Photolysis of N-aryl phenyltellurotrifluoroacetimidates generates N-aryl trifluoroacetimidoyl radicals, which undergo an intramolecular exo-attack to carbon-carbon triple bond leading to indole derivatives.

N-[4-(phenyl telluro) butyl] phthalimide: Synthesis, spectral characterization, DFT studies and its complexes with mercury salts

Reaction of N-[4?bromo butyl] phthalimide) with C6H5Te?Na+ (generated insitu) under N2 environment gives N-[4-(phenyl telluro)butyl] phthalimide (L) as a cream color solid. Interaction of the L with d

Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity

A series of disubstituted selenazole derivatives was synthetized and evaluated as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors against the human (h) isoforms hCA I, II, IV, VA, VB and IX, involved in a variety of diseases including glaucoma, retinitis pigmentosa, epilepsy, arthritis and tumors. The investigated compounds showed potent inhibition against the tumor-associated transmembrane hCA IX, with KIs in the subnanomolar – low nanomolar range, and were evaluated for their effects on cell viability against the human prostate (PC3) and breast (MDA-MB-231) cancer cell lines, showing effective anti-tumor activity. These selenazoles are interesting leads for the development of new, isoform-selective CA IX inhibitors.

Structural variation in [PdX2{RE(CH2)nNMe2}] (E = Se, Te; X = Cl, OAc) complexes: Experimental results, computational analysis, and catalytic activity in Suzuki coupling reactions

A series of chalcogenoether ligands RE(CH2)nNMe2 (1) [E = Se or Te; R = Ph, o-tol (o-tol = ortho-tolyl), Mes (Mes = 2,4,6-trimethylphenyl); n = 2 or 3] and their palladium complexes [PdX2{RE(CH2)